Claire is Co-founder and Director at NanoScientium. Here, she enables investors, developers and corporations to fast-track their nanotechnologies into products and profits. She is also Founder and Director at Agility Health Tech, experts in technical and corporate communications and strategy. Claire’s Pharmaceutical Industry experience spans large multi-national, virtual and contract research organisations. Before founding NanoScientium, she was Head of Research and Development with Oxford PharmaScience, an AIM-listed virtual Pharmaceutical company identified as one of the "Top 10 Emerging Technology Companies 2012". Prior to this, Claire was Associate Director at Molecular Profiles where her role was split between managing a Technical Division and developing and marketing new Client services. Claire spent 6 years at GSK developing novel molecules and formulations for therapeutic areas such as asthma, cancer, HIV, insomnia, malaria and pain. She attained increasingly senior roles leading global technical teams across R&D and manufacturing to deliver projects to milestones throughout the development lifecycle. She started her Industrial career at Pfizer developing highly sensitive, novel methods to characterise inhaled and intranasal drugs. Claire is Chief Scientist of the Academy of Pharmaceutical Sciences. She is Honorary Senior Lecturer in the College of Medical & Dental Sciences at the University of Birmingham. She holds a PhD from School of Pharmacy, University of Nottingham, and a BSc in Biochemistry from the University of St. Andrews.